HelixAccel

We are building something ambitious: the compute layer for biology—think NVIDIA, but purpose-built for genomics and drug discovery.

We’re tackling a fundamental gap: today’s GPUs are optimized for LLMs, not biological workloads (sparse data, sequence alignment, molecular modeling). This creates massive inefficiencies and cost issues across pharma and bio-AI.